24/7 Emergency & General Advisory
π¨ 24/7 Medical Emergency
Non-Emergency Advisory
10:00 AM β 6:00 PM, MonβSat
For appointments & general queries.
Join our healthcare community
Stay updated with our latest healthcare news and your appointments.
An in-depth look at Multiple System Atrophy (MSA), formerly Shy Drager Syndrome. Learn about its symptoms, causes, diagnosis, and management.

Multiple System Atrophy (MSA) is a rare, progressive neurodegenerative disorder that affects the autonomic nervous system, which controls involuntary bodily functions like blood pressure, heart rate, digestion, and bladder control. It was formerly known as Shy Drager Syndrome, a name given in the 1960s by Dr. Milton Shy and Dr. Glen Drager. The name was changed in 1998 to better reflect the wide-ranging impact of the condition on multiple body systems.
MSA is characterized by the gradual loss of control and coordination over various bodily functions. The condition typically manifests in individuals around the age of 60, with men being twice as likely to develop it as women. The incidence of MSA is low, with approximately 0.6 to 0.7 new cases per 100,000 people diagnosed annually. The disease progresses over time, and many individuals may become wheelchair-bound within 5 to 6 years of diagnosis due to declining motor skills.
The shift from Shy Drager Syndrome to Multiple System Atrophy (MSA) was a significant update in the medical community's understanding of the condition. The original name, Shy Drager Syndrome, primarily focused on the autonomic dysfunction, particularly orthostatic hypotension (a drop in blood pressure upon standing). However, as research advanced, it became clear that MSA affected a broader spectrum of neurological functions, including motor control, coordination, and other involuntary processes.
In 1998, a consensus statement was published, leading to the name change and a clearer definition of the disease. This update aimed to encompass the diverse symptoms and the underlying pathology more accurately. The new classification also introduced two main subtypes of MSA:
This section adds practical context and preventive advice to help readers make informed healthcare decisions. It is important to verify symptoms early, consult qualified doctors, and avoid self-medication for persistent health issues.
Maintaining healthy routines, following prescribed treatment plans, and attending regular checkups can improve outcomes. If symptoms worsen or red-flag signs appear, immediate medical evaluation is recommended.
Track symptoms and duration.
Follow diagnosis and treatment from a licensed practitioner.
Review medication side effects with your doctor.
Seek urgent care for severe warning signs.
Visit Hospital
Near You

Can a simple blood draw really predict dementia decades before memory problems start? In 2026, several major studies said yes β one found a protein called p-tau217 predicted risk up to 25 years ahead in women, while another found a 78% risk of cognitive impairment within 10 years in people with the
July 23, 2026

Learn about Parkinson's disease symptoms, causes, stages, and treatment options. A complete guide for patients and caregivers in simple language.
June 13, 2026
Seeking a brain specialist in Kamarhati? Doctar connects you with leading neurologists and neurosurgeons for expert care. Book appointments now.
May 20, 2026